Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02405754 · ClinicalTrials.gov registry record
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 667
- Enrollment target
NCT02405754 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 667 participants.
The verdict
NCT02405754 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 667 participants
- Enrollment target
Study Summary
This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investigator. Limited demographic data and patient data pertaining to cardiology referral or advanced diagnostic testing will be collected. All data will be collected anonymously.
Interventions
- DIAGNOSTIC_TEST Corus CAD (ASGES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 667 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02405754
The ClinicalTrials.gov registry entry for NCT02405754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 667 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD (ASGES) is the first listed.
NCT02405754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02405754 about?
NCT02405754 is a clinical study titled "Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.". This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investi...
What is the current status of trial NCT02405754?
This trial is currently completed. The enrollment target is 667 participants. The study started on 2014-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02405754?
The interventions under investigation include: Corus CAD (ASGES) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02405754?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.